Conference
Abstract P6-07-02: Pharmacoeconomic evaluation of denosumab for the treatment of bone metastases in patients with advanced breast cancer in Canada
Abstract
Abstract
Background: Skeletal-related events (SREs) occur in 80% of patients with advanced breast cancer (BC) and bone metastases. SREs are costly and can be painful and debilitating, impacting patients’ quality of life and morbidity. While intravenous bisphosphonates such as pamidronate (PAM) and zoledronic acid (ZA) have demonstrated clinical benefit in reducing SREs, skeletal metastases remain a problem as treatments that …
Authors
Habib M; Risebrough N; Moore P; Kendall R; Li C; Goeree R
Volume
73
Publisher
American Association for Cancer Research (AACR)
Publication Date
December 15, 2013
DOI
10.1158/0008-5472.sabcs13-p6-07-02
Conference proceedings
Cancer Research
Issue
24_Supplement
ISSN
0008-5472